These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10923014)

  • 1. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
    Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
    Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL
    Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
    Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
    Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice.
    Vallespi MG; Alvarez-Obregón JC; Rodriguez-Alonso I; Montero T; Garay H; Reyes O; Araña MJ
    Int Immunopharmacol; 2003 Feb; 3(2):247-56. PubMed ID: 12586605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of in vitro endotoxin neutralization effect and antibacterial activity of limulus anti-lipopolysaccharide factor simulated peptide REMP2].
    Gao HF; Xiao GX; Xia PY; Ren JD
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):90-2. PubMed ID: 18785404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide (LPS) detoxification of analogue peptides derived from limulus anti-LPS factor.
    Ren J; Gao H; Tang M; Gu J; Xia P; Xiao G
    Peptides; 2010 Oct; 31(10):1853-9. PubMed ID: 20624438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of Th1/Th2 in relevant tissues for sepsis pathogenesis with a Limulus anti-LPS factor-derived peptide increases survival in Gram-positive sepsis.
    Vallespi MG; Colas M; Garay H; Reyes O; Araña MJ
    Int Immunopharmacol; 2004 Oct; 4(10-11):1343-51. PubMed ID: 15313432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
    Wasiluk KR; Leslie DB; Vietzen PS; Mayo KH; Dunn DL
    Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases.
    Vallespi MG; Glaria LA; Reyes O; Garay HE; Ferrero J; Araña MJ
    Clin Diagn Lab Immunol; 2000 Jul; 7(4):669-75. PubMed ID: 10882670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
    Dankesreiter S; Hoess A; Schneider-Mergener J; Wagner H; Miethke T
    J Immunol; 2000 May; 164(9):4804-11. PubMed ID: 10779788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a synthetic fragment of the LALF protein when bound to lipopolysaccharide.
    Pristovsek P; Fehér K; Szilágyi L; Kidric J
    J Med Chem; 2005 Mar; 48(5):1666-70. PubMed ID: 15743208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation.
    Tsuzuki H; Tani T; Ueyama H; Kodama M
    J Surg Res; 2001 Sep; 100(1):127-34. PubMed ID: 11516215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
    Lee EK; Kim YC; Nan YH; Shin SY
    Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY; Chao TT; Chen JC; Chen JY; Liu WC; Lin CH; Kuo CM
    Int Immunopharmacol; 2007 May; 7(5):687-700. PubMed ID: 17386416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
    Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
    Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.